Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.39996032 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.39996032 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.18678556 |
4 | L-phenylalanine metabolic process (GO:0006558) | 7.18678556 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.61900725 |
6 | glyoxylate metabolic process (GO:0046487) | 6.13634486 |
7 | cysteine metabolic process (GO:0006534) | 5.98006169 |
8 | tryptophan catabolic process (GO:0006569) | 5.91255904 |
9 | indole-containing compound catabolic process (GO:0042436) | 5.91255904 |
10 | indolalkylamine catabolic process (GO:0046218) | 5.91255904 |
11 | kynurenine metabolic process (GO:0070189) | 5.66804693 |
12 | tryptophan metabolic process (GO:0006568) | 5.59138408 |
13 | bile acid biosynthetic process (GO:0006699) | 5.56631158 |
14 | lysine metabolic process (GO:0006553) | 5.49727291 |
15 | lysine catabolic process (GO:0006554) | 5.49727291 |
16 | sulfur amino acid catabolic process (GO:0000098) | 5.48371752 |
17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.46093375 |
18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.44070945 |
19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.21969446 |
20 | serine family amino acid catabolic process (GO:0009071) | 5.17244500 |
21 | proline biosynthetic process (GO:0006561) | 5.17088902 |
22 | Golgi transport vesicle coating (GO:0048200) | 5.10460659 |
23 | COPI coating of Golgi vesicle (GO:0048205) | 5.10460659 |
24 | urea metabolic process (GO:0019627) | 4.93515384 |
25 | urea cycle (GO:0000050) | 4.93515384 |
26 | aromatic amino acid family metabolic process (GO:0009072) | 4.87106974 |
27 | homocysteine metabolic process (GO:0050667) | 4.83294196 |
28 | amino-acid betaine metabolic process (GO:0006577) | 4.79104948 |
29 | bile acid metabolic process (GO:0008206) | 4.71949538 |
30 | negative regulation of fibrinolysis (GO:0051918) | 4.69320391 |
31 | alpha-amino acid catabolic process (GO:1901606) | 4.64908374 |
32 | cellular ketone body metabolic process (GO:0046950) | 4.63497817 |
33 | high-density lipoprotein particle remodeling (GO:0034375) | 4.63030447 |
34 | nitrogen cycle metabolic process (GO:0071941) | 4.59925792 |
35 | serine family amino acid metabolic process (GO:0009069) | 4.59601843 |
36 | protein carboxylation (GO:0018214) | 4.58305389 |
37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.58305389 |
38 | complement activation, alternative pathway (GO:0006957) | 4.54429585 |
39 | tyrosine metabolic process (GO:0006570) | 4.50414008 |
40 | drug transmembrane transport (GO:0006855) | 4.47218419 |
41 | regulation of fibrinolysis (GO:0051917) | 4.43558784 |
42 | regulation of protein activation cascade (GO:2000257) | 4.43545324 |
43 | serine family amino acid biosynthetic process (GO:0009070) | 4.42607543 |
44 | urate metabolic process (GO:0046415) | 4.41500943 |
45 | glycine metabolic process (GO:0006544) | 4.41358596 |
46 | cellular amino acid catabolic process (GO:0009063) | 4.40710248 |
47 | regulation of triglyceride catabolic process (GO:0010896) | 4.40044771 |
48 | short-chain fatty acid metabolic process (GO:0046459) | 4.38565422 |
49 | cellular modified amino acid catabolic process (GO:0042219) | 4.28168342 |
50 | coenzyme catabolic process (GO:0009109) | 4.25463874 |
51 | regulation of translational fidelity (GO:0006450) | 4.21947616 |
52 | acetyl-CoA metabolic process (GO:0006084) | 4.21684056 |
53 | ethanol oxidation (GO:0006069) | 4.21395939 |
54 | drug catabolic process (GO:0042737) | 4.19777918 |
55 | glutamate metabolic process (GO:0006536) | 4.18706710 |
56 | indolalkylamine metabolic process (GO:0006586) | 4.18147501 |
57 | regulation of complement activation (GO:0030449) | 4.15656979 |
58 | negative regulation of cholesterol transport (GO:0032375) | 4.14097241 |
59 | negative regulation of sterol transport (GO:0032372) | 4.14097241 |
60 | triglyceride homeostasis (GO:0070328) | 4.13266086 |
61 | acylglycerol homeostasis (GO:0055090) | 4.13266086 |
62 | amine catabolic process (GO:0009310) | 4.08646283 |
63 | cellular biogenic amine catabolic process (GO:0042402) | 4.08646283 |
64 | aspartate family amino acid catabolic process (GO:0009068) | 4.06912366 |
65 | fatty acid beta-oxidation (GO:0006635) | 4.04477660 |
66 | protein maturation by protein folding (GO:0022417) | 4.03363008 |
67 | proline metabolic process (GO:0006560) | 4.03060194 |
68 | regulation of cholesterol esterification (GO:0010872) | 4.02679137 |
69 | benzene-containing compound metabolic process (GO:0042537) | 4.02148197 |
70 | reverse cholesterol transport (GO:0043691) | 4.01994801 |
71 | ketone body metabolic process (GO:1902224) | 4.01962714 |
72 | plasma lipoprotein particle remodeling (GO:0034369) | 4.00708790 |
73 | protein-lipid complex remodeling (GO:0034368) | 4.00708790 |
74 | macromolecular complex remodeling (GO:0034367) | 4.00708790 |
75 | aldehyde catabolic process (GO:0046185) | 4.00340332 |
76 | carboxylic acid catabolic process (GO:0046395) | 3.99088750 |
77 | organic acid catabolic process (GO:0016054) | 3.99088750 |
78 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.95717663 |
79 | fatty acid oxidation (GO:0019395) | 3.95007159 |
80 | bile acid and bile salt transport (GO:0015721) | 3.92424940 |
81 | valine metabolic process (GO:0006573) | 3.91729926 |
82 | plasma lipoprotein particle clearance (GO:0034381) | 3.91170616 |
83 | protein retention in ER lumen (GO:0006621) | 3.91064042 |
84 | cellular glucuronidation (GO:0052695) | 3.89003728 |
85 | 2-oxoglutarate metabolic process (GO:0006103) | 3.87125368 |
86 | lipid oxidation (GO:0034440) | 3.86845846 |
87 | pentose-phosphate shunt (GO:0006098) | 3.84662889 |
88 | imidazole-containing compound metabolic process (GO:0052803) | 3.83397818 |
89 | fatty acid catabolic process (GO:0009062) | 3.82863899 |
90 | monocarboxylic acid catabolic process (GO:0072329) | 3.81924795 |
91 | drug transport (GO:0015893) | 3.79454516 |
92 | exogenous drug catabolic process (GO:0042738) | 3.79160430 |
93 | phospholipid efflux (GO:0033700) | 3.71709450 |
94 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.71026576 |
95 | carnitine metabolic process (GO:0009437) | 3.70637556 |
96 | branched-chain amino acid catabolic process (GO:0009083) | 3.69339715 |
97 | glucose 6-phosphate metabolic process (GO:0051156) | 3.63639924 |
98 | arginine metabolic process (GO:0006525) | 3.62878051 |
99 | branched-chain amino acid metabolic process (GO:0009081) | 3.61332098 |
100 | GDP-mannose metabolic process (GO:0019673) | 3.59562178 |
101 | regulation of cholesterol homeostasis (GO:2000188) | 3.59467869 |
102 | NADPH regeneration (GO:0006740) | 3.56379539 |
103 | drug metabolic process (GO:0017144) | 3.54717536 |
104 | pinocytosis (GO:0006907) | 3.53685469 |
105 | glucose catabolic process (GO:0006007) | 3.53048344 |
106 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.52404887 |
107 | glucuronate metabolic process (GO:0019585) | 3.51343868 |
108 | uronic acid metabolic process (GO:0006063) | 3.51343868 |
109 | cofactor catabolic process (GO:0051187) | 3.50889242 |
110 | heme transport (GO:0015886) | 3.49569369 |
111 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.46999894 |
112 | flavonoid metabolic process (GO:0009812) | 3.45713087 |
113 | response to nitrosative stress (GO:0051409) | 3.45542585 |
114 | cholesterol homeostasis (GO:0042632) | 3.43473655 |
115 | cholesterol efflux (GO:0033344) | 3.42803824 |
116 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.41820574 |
117 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.35748102 |
118 | oxaloacetate metabolic process (GO:0006107) | 3.35599508 |
119 | plasma lipoprotein particle assembly (GO:0034377) | 3.25493811 |
120 | NADH metabolic process (GO:0006734) | 3.22072562 |
121 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.12371545 |
122 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.09045669 |
123 | ribosomal small subunit biogenesis (GO:0042274) | 3.08173128 |
124 | regulation of superoxide anion generation (GO:0032928) | 3.04623471 |
125 | protein-lipid complex assembly (GO:0065005) | 3.02030460 |
126 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.97207117 |
127 | monosaccharide biosynthetic process (GO:0046364) | 2.96704226 |
128 | formation of translation preinitiation complex (GO:0001731) | 2.94451319 |
129 | pentose metabolic process (GO:0019321) | 2.90484892 |
130 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.85062348 |
131 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.84159872 |
132 | tricarboxylic acid metabolic process (GO:0072350) | 2.82626251 |
133 | positive regulation of nuclease activity (GO:0032075) | 2.80424789 |
134 | low-density lipoprotein particle clearance (GO:0034383) | 2.80217421 |
135 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.79219816 |
136 | folic acid metabolic process (GO:0046655) | 2.78409475 |
137 | DNA unwinding involved in DNA replication (GO:0006268) | 2.74540911 |
138 | gluconeogenesis (GO:0006094) | 2.73815728 |
139 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.70726108 |
140 | regulation of translational termination (GO:0006449) | 2.69401482 |
141 | regulation of early endosome to late endosome transport (GO:2000641) | 2.68689827 |
142 | hexose biosynthetic process (GO:0019319) | 2.68187070 |
143 | L-serine metabolic process (GO:0006563) | 2.63093852 |
144 | 4-hydroxyproline metabolic process (GO:0019471) | 2.62375465 |
145 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.60119190 |
146 | regulation of nuclease activity (GO:0032069) | 2.56921526 |
147 | UV protection (GO:0009650) | 2.51118423 |
148 | negative regulation of cell size (GO:0045792) | 2.48636666 |
149 | regulation of cholesterol metabolic process (GO:0090181) | 2.47779635 |
150 | glycolytic process (GO:0006096) | 2.46039343 |
151 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.45195128 |
152 | basement membrane organization (GO:0071711) | 2.44648278 |
153 | mitotic chromosome condensation (GO:0007076) | 2.44483820 |
154 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.44347301 |
155 | apoptotic process involved in morphogenesis (GO:0060561) | 2.44019854 |
156 | nuclear envelope reassembly (GO:0031468) | 2.43994008 |
157 | mitotic nuclear envelope reassembly (GO:0007084) | 2.43994008 |
158 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.43021847 |
159 | glycosphingolipid catabolic process (GO:0046479) | 2.42755437 |
160 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.40486092 |
161 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.40299681 |
162 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.35593318 |
163 | ER-nucleus signaling pathway (GO:0006984) | 2.34616192 |
164 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.33332183 |
165 | glycolipid catabolic process (GO:0019377) | 2.31715269 |
166 | pyrimidine-containing compound salvage (GO:0008655) | 2.31482236 |
167 | pyrimidine nucleoside salvage (GO:0043097) | 2.31482236 |
168 | mitochondrial fusion (GO:0008053) | 2.30808818 |
169 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.30076071 |
170 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.28508876 |
171 | activation of Rac GTPase activity (GO:0032863) | 2.28033710 |
172 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.27805786 |
173 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.26768033 |
174 | cellular response to unfolded protein (GO:0034620) | 2.24799492 |
175 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.24416494 |
176 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.23804931 |
177 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.23505751 |
178 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.23193253 |
179 | heterochromatin organization (GO:0070828) | 2.22129693 |
180 | cellular modified amino acid biosynthetic process (GO:0042398) | 2.20511665 |
181 | intestinal cholesterol absorption (GO:0030299) | 2.19986616 |
182 | desmosome organization (GO:0002934) | 2.19854424 |
183 | folic acid-containing compound metabolic process (GO:0006760) | 2.19801987 |
184 | nucleotide salvage (GO:0043173) | 2.19508740 |
185 | establishment of integrated proviral latency (GO:0075713) | 2.19288806 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.97351884 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.96506976 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.13962847 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.09255306 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.00725141 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.86998703 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.78290484 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.01568186 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.50011807 |
10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.70915280 |
11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.66470597 |
12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.47509455 |
13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.35525270 |
14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.29848368 |
15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.24063471 |
16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.20814132 |
17 | MYC_22102868_ChIP-Seq_BL_Human | 2.19464060 |
18 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.10316601 |
19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03418789 |
20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.02964979 |
21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2537408 |
22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.93219748 |
23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.85455747 |
24 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.78674141 |
25 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.74764519 |
26 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.72686529 |
27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.72309028 |
28 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.69725595 |
29 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.64677535 |
30 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.62291264 |
31 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.48905968 |
32 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47990756 |
33 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47075927 |
34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46849761 |
35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.41382133 |
36 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.38499987 |
37 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.37826304 |
38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37813521 |
39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37775579 |
40 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35503508 |
41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.35073345 |
42 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34859227 |
43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34644191 |
44 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.34504842 |
45 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.33715408 |
46 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.31719027 |
47 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30361353 |
48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28650525 |
49 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.28562726 |
50 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.28171274 |
51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.26667303 |
52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.26354702 |
53 | ATF3_27146783_Chip-Seq_COLON_Human | 1.25882785 |
54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.25569591 |
55 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22029162 |
56 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.21984870 |
57 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.21108764 |
58 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20122801 |
59 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.19699590 |
60 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.19368303 |
61 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19137500 |
62 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.18722887 |
63 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18711383 |
64 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.18441758 |
65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.18099322 |
66 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17862008 |
67 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17755831 |
68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17607312 |
69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17254827 |
70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.17232922 |
71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16659983 |
72 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16232926 |
73 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13327818 |
74 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11598538 |
75 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10336737 |
76 | MAF_26560356_Chip-Seq_TH1_Human | 1.10249205 |
77 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08860388 |
78 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08632314 |
79 | * ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08274554 |
80 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.08076094 |
81 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07654733 |
82 | MAF_26560356_Chip-Seq_TH2_Human | 1.06440911 |
83 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05195871 |
84 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04711642 |
85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04121115 |
86 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03721445 |
87 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.03242219 |
88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03091181 |
89 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.01724767 |
90 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.01599164 |
91 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01134797 |
92 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00209999 |
93 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99652396 |
94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.99450016 |
95 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.99417834 |
96 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96879358 |
97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96447406 |
98 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.95779170 |
99 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.93911039 |
100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92974452 |
101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91162236 |
102 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.90441697 |
103 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89971641 |
104 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.89732935 |
105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88807033 |
106 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.85215651 |
107 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.79832328 |
108 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.79669272 |
109 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78384892 |
110 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.74087024 |
111 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.73432079 |
112 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.72800504 |
113 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.70696993 |
114 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70311712 |
115 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.70201250 |
116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67913011 |
117 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.67533900 |
118 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.67331498 |
119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65321413 |
120 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.65153628 |
121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64444601 |
122 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.62646906 |
123 | AR_20517297_ChIP-Seq_VCAP_Human | 0.61559443 |
124 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.60632507 |
125 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.59804778 |
126 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59363225 |
127 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.59232072 |
128 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.58880024 |
129 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.56824353 |
130 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56780540 |
131 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.55708830 |
132 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.54082711 |
133 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53912559 |
134 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.53714798 |
135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.53290156 |
136 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52991213 |
137 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52898864 |
138 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.52812635 |
139 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.52633929 |
140 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.52610470 |
141 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.52220961 |
142 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.51883373 |
143 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.50944870 |
144 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50675015 |
145 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.50096256 |
146 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.49856478 |
147 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49411578 |
148 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.48016561 |
149 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.47995107 |
150 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47707595 |
151 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.47598611 |
152 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.47272982 |
153 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46387879 |
154 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.46127319 |
155 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.45573304 |
156 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.45546308 |
157 | P300_27268052_Chip-Seq_Bcells_Human | 0.45061226 |
158 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.44132709 |
159 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.43737542 |
160 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.43708800 |
161 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.43198174 |
162 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.43114445 |
163 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.42892845 |
164 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.42299663 |
165 | P68_20966046_ChIP-Seq_HELA_Human | 0.42242427 |
166 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.42104667 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.90394350 |
2 | MP0005360_urolithiasis | 7.59631148 |
3 | MP0005365_abnormal_bile_salt | 5.86964588 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.86679091 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.86747260 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.24038521 |
7 | MP0003252_abnormal_bile_duct | 3.63796058 |
8 | MP0010329_abnormal_lipoprotein_level | 3.35032553 |
9 | MP0005332_abnormal_amino_acid | 3.30640626 |
10 | MP0003195_calcinosis | 3.10568825 |
11 | MP0009840_abnormal_foam_cell | 3.04048894 |
12 | MP0005083_abnormal_biliary_tract | 2.90519112 |
13 | MP0008260_abnormal_autophagy | 2.74258770 |
14 | MP0001666_abnormal_nutrient_absorption | 2.69226408 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.60988178 |
16 | MP0003172_abnormal_lysosome_physiology | 2.44173886 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.28157194 |
18 | MP0002118_abnormal_lipid_homeostasis | 2.15048646 |
19 | MP0002138_abnormal_hepatobiliary_system | 2.11905912 |
20 | MP0000609_abnormal_liver_physiology | 2.10163888 |
21 | MP0001849_ear_inflammation | 2.06765764 |
22 | MP0003111_abnormal_nucleus_morphology | 2.05992179 |
23 | MP0000678_abnormal_parathyroid_gland | 1.97915920 |
24 | MP0003693_abnormal_embryo_hatching | 1.97242192 |
25 | MP0005319_abnormal_enzyme/_coenzyme | 1.91155893 |
26 | MP0009643_abnormal_urine_homeostasis | 1.85576342 |
27 | MP0009333_abnormal_splenocyte_physiolog | 1.79480845 |
28 | MP0005076_abnormal_cell_differentiation | 1.77674338 |
29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.76664079 |
30 | MP0003436_decreased_susceptibility_to | 1.75697376 |
31 | MP0000858_altered_metastatic_potential | 1.73069719 |
32 | MP0001764_abnormal_homeostasis | 1.72802877 |
33 | MP0003868_abnormal_feces_composition | 1.72327595 |
34 | MP0003566_abnormal_cell_adhesion | 1.70319862 |
35 | MP0004957_abnormal_blastocyst_morpholog | 1.67143350 |
36 | MP0003186_abnormal_redox_activity | 1.66837380 |
37 | MP0002877_abnormal_melanocyte_morpholog | 1.62429882 |
38 | MP0004858_abnormal_nervous_system | 1.61754396 |
39 | MP0001730_embryonic_growth_arrest | 1.56574812 |
40 | MP0005501_abnormal_skin_physiology | 1.56394849 |
41 | MP0002132_abnormal_respiratory_system | 1.55793419 |
42 | MP0003453_abnormal_keratinocyte_physiol | 1.51266895 |
43 | MP0004233_abnormal_muscle_weight | 1.48392026 |
44 | MP0005451_abnormal_body_composition | 1.45688218 |
45 | MP0005636_abnormal_mineral_homeostasis | 1.37930541 |
46 | MP0002089_abnormal_postnatal_growth/wei | 1.34310421 |
47 | MP0005670_abnormal_white_adipose | 1.33955948 |
48 | MP0009278_abnormal_bone_marrow | 1.29739361 |
49 | MP0006036_abnormal_mitochondrial_physio | 1.27679539 |
50 | MP0003077_abnormal_cell_cycle | 1.26858796 |
51 | MP0003123_paternal_imprinting | 1.26746899 |
52 | MP0000490_abnormal_crypts_of | 1.25147808 |
53 | MP0003315_abnormal_perineum_morphology | 1.23197334 |
54 | MP0004043_abnormal_pH_regulation | 1.21291000 |
55 | MP0000598_abnormal_liver_morphology | 1.20800808 |
56 | MP0003656_abnormal_erythrocyte_physiolo | 1.20686511 |
57 | MP0001853_heart_inflammation | 1.20652228 |
58 | MP0003011_delayed_dark_adaptation | 1.17573124 |
59 | MP0008932_abnormal_embryonic_tissue | 1.15109860 |
60 | MP0005257_abnormal_intraocular_pressure | 1.14466508 |
61 | MP0009697_abnormal_copulation | 1.13585032 |
62 | MP0003303_peritoneal_inflammation | 1.11331161 |
63 | MP0001756_abnormal_urination | 1.10113999 |
64 | MP0002080_prenatal_lethality | 1.07053407 |
65 | MP0000350_abnormal_cell_proliferation | 1.05488960 |
66 | MP0000003_abnormal_adipose_tissue | 1.04637292 |
67 | MP0004947_skin_inflammation | 1.02295848 |
68 | MP0003705_abnormal_hypodermis_morpholog | 1.01084251 |
69 | MP0000604_amyloidosis | 1.00801771 |
70 | MP0005220_abnormal_exocrine_pancreas | 1.00511455 |
71 | MP0000313_abnormal_cell_death | 1.00487593 |
72 | MP0005084_abnormal_gallbladder_morpholo | 0.98270814 |
73 | MP0002396_abnormal_hematopoietic_system | 0.97355282 |
74 | MP0005647_abnormal_sex_gland | 0.96583096 |
75 | MP0010094_abnormal_chromosome_stability | 0.95129092 |
76 | MP0000358_abnormal_cell_content/ | 0.94852154 |
77 | MP0000681_abnormal_thyroid_gland | 0.93939928 |
78 | MP0009642_abnormal_blood_homeostasis | 0.93402609 |
79 | MP0005409_darkened_coat_color | 0.93159382 |
80 | MP0002876_abnormal_thyroid_physiology | 0.92729480 |
81 | MP0005023_abnormal_wound_healing | 0.92624585 |
82 | MP0001661_extended_life_span | 0.91234555 |
83 | MP0005058_abnormal_lysosome_morphology | 0.90223481 |
84 | MP0002078_abnormal_glucose_homeostasis | 0.89199712 |
85 | MP0008469_abnormal_protein_level | 0.88702399 |
86 | MP0009763_increased_sensitivity_to | 0.88175732 |
87 | MP0001915_intracranial_hemorrhage | 0.87621728 |
88 | MP0002971_abnormal_brown_adipose | 0.87590318 |
89 | MP0002136_abnormal_kidney_physiology | 0.86900109 |
90 | MP0009764_decreased_sensitivity_to | 0.86533476 |
91 | MP0000685_abnormal_immune_system | 0.86427421 |
92 | MP0001216_abnormal_epidermal_layer | 0.85559682 |
93 | MP0005535_abnormal_body_temperature | 0.84057689 |
94 | MP0005666_abnormal_adipose_tissue | 0.82351125 |
95 | MP0005025_abnormal_response_to | 0.82267951 |
96 | MP0005621_abnormal_cell_physiology | 0.82223292 |
97 | MP0004130_abnormal_muscle_cell | 0.82152951 |
98 | MP0002019_abnormal_tumor_incidence | 0.81941472 |
99 | MP0005408_hypopigmentation | 0.81088122 |
100 | MP0008007_abnormal_cellular_replicative | 0.80592829 |
101 | MP0005384_cellular_phenotype | 0.79617590 |
102 | MP0005330_cardiomyopathy | 0.79092517 |
103 | MP0001873_stomach_inflammation | 0.78504535 |
104 | MP0002086_abnormal_extraembryonic_tissu | 0.78494052 |
105 | MP0005380_embryogenesis_phenotype | 0.76991635 |
106 | MP0001672_abnormal_embryogenesis/_devel | 0.76991635 |
107 | MP0009931_abnormal_skin_appearance | 0.76374303 |
108 | MP0003984_embryonic_growth_retardation | 0.76128321 |
109 | MP0005334_abnormal_fat_pad | 0.76127399 |
110 | MP0005376_homeostasis/metabolism_phenot | 0.75721484 |
111 | MP0003329_amyloid_beta_deposits | 0.75417825 |
112 | MP0001765_abnormal_ion_homeostasis | 0.74232867 |
113 | MP0009765_abnormal_xenobiotic_induced | 0.73905807 |
114 | MP0010155_abnormal_intestine_physiology | 0.72908178 |
115 | MP0001697_abnormal_embryo_size | 0.72865110 |
116 | MP0006035_abnormal_mitochondrial_morpho | 0.72382267 |
117 | MP0005397_hematopoietic_system_phenotyp | 0.70358080 |
118 | MP0005266_abnormal_metabolism | 0.66286822 |
119 | MP0003690_abnormal_glial_cell | 0.62110913 |
120 | MP0002254_reproductive_system_inflammat | 0.55180319 |
121 | MP0005448_abnormal_energy_balance | 0.53585984 |
122 | MP0003638_abnormal_response/metabolism_ | 0.52763232 |
123 | MP0010368_abnormal_lymphatic_system | 0.52088641 |
124 | MP0003953_abnormal_hormone_level | 0.52050530 |
125 | MP0002928_abnormal_bile_duct | 0.51955467 |
126 | MP0005395_other_phenotype | 0.49750745 |
127 | MP0000639_abnormal_adrenal_gland | 0.49214777 |
128 | MP0009672_abnormal_birth_weight | 0.49080934 |
129 | MP0002970_abnormal_white_adipose | 0.47327262 |
130 | MP0003959_abnormal_lean_body | 0.47323116 |
131 | MP0000230_abnormal_systemic_arterial | 0.45889611 |
132 | MP0008873_increased_physiological_sensi | 0.45433794 |
133 | MP0004782_abnormal_surfactant_physiolog | 0.41953427 |
134 | MP0002168_other_aberrant_phenotype | 0.40941556 |
135 | MP0009115_abnormal_fat_cell | 0.40886359 |
136 | MP0002135_abnormal_kidney_morphology | 0.40315337 |
137 | MP0004264_abnormal_extraembryonic_tissu | 0.40081991 |
138 | MP0002796_impaired_skin_barrier | 0.40035761 |
139 | MP0009053_abnormal_anal_canal | 0.39755193 |
140 | MP0003724_increased_susceptibility_to | 0.38981881 |
141 | MP0001944_abnormal_pancreas_morphology | 0.38346859 |
142 | MP0003718_maternal_effect | 0.38140388 |
143 | MP0004147_increased_porphyrin_level | 0.37354765 |
144 | MP0002837_dystrophic_cardiac_calcinosis | 0.37048154 |
145 | MP0005375_adipose_tissue_phenotype | 0.36933760 |
146 | MP0000538_abnormal_urinary_bladder | 0.35724593 |
147 | MP0005464_abnormal_platelet_physiology | 0.35231693 |
148 | MP0008872_abnormal_physiological_respon | 0.33821757 |
149 | MP0010234_abnormal_vibrissa_follicle | 0.32585038 |
150 | MP0008874_decreased_physiological_sensi | 0.32452926 |
151 | MP0001845_abnormal_inflammatory_respons | 0.30056449 |
152 | MP0004185_abnormal_adipocyte_glucose | 0.28774668 |
153 | MP0003300_gastrointestinal_ulcer | 0.28378290 |
154 | MP0001881_abnormal_mammary_gland | 0.27724918 |
155 | MP0005452_abnormal_adipose_tissue | 0.27418254 |
156 | MP0003075_altered_response_to | 0.25283728 |
157 | MP0009384_cardiac_valve_regurgitation | 0.24769621 |
158 | MP0005166_decreased_susceptibility_to | 0.23940260 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.96977759 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.29873042 |
3 | Deep venous thrombosis (HP:0002625) | 6.03357884 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.77213677 |
5 | Xanthomatosis (HP:0000991) | 5.63749476 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.37966868 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.13378130 |
8 | Ketosis (HP:0001946) | 4.77517450 |
9 | Hyperammonemia (HP:0001987) | 4.76042373 |
10 | Hyperglycinuria (HP:0003108) | 4.75763383 |
11 | Hyperlipoproteinemia (HP:0010980) | 4.75524301 |
12 | Hyperglycinemia (HP:0002154) | 4.61401758 |
13 | Abnormality of glycine metabolism (HP:0010895) | 4.57293637 |
14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.57293637 |
15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.52378357 |
16 | Complement deficiency (HP:0004431) | 4.30641939 |
17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.14108704 |
18 | Hypoglycemic coma (HP:0001325) | 4.10348938 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.07656514 |
20 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.01454098 |
21 | Hypolipoproteinemia (HP:0010981) | 3.96591099 |
22 | Ketoacidosis (HP:0001993) | 3.88168666 |
23 | Epidermoid cyst (HP:0200040) | 3.77747754 |
24 | Joint hemorrhage (HP:0005261) | 3.76770303 |
25 | Fat malabsorption (HP:0002630) | 3.69308489 |
26 | Gout (HP:0001997) | 3.68435003 |
27 | Abnormality of methionine metabolism (HP:0010901) | 3.67876476 |
28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.65393984 |
29 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.63421845 |
30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.62469616 |
31 | Delayed CNS myelination (HP:0002188) | 3.49091364 |
32 | Hypoalphalipoproteinemia (HP:0003233) | 3.39560513 |
33 | Abnormality of purine metabolism (HP:0004352) | 3.39465332 |
34 | Abnormality of nucleobase metabolism (HP:0010932) | 3.38536589 |
35 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.38334175 |
36 | Dicarboxylic aciduria (HP:0003215) | 3.38334175 |
37 | Vertebral compression fractures (HP:0002953) | 3.37906863 |
38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.36679102 |
39 | Conjugated hyperbilirubinemia (HP:0002908) | 3.21056623 |
40 | Abnormality of serum amino acid levels (HP:0003112) | 3.18437183 |
41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.17116624 |
42 | Hyperbilirubinemia (HP:0002904) | 3.16178300 |
43 | Generalized aminoaciduria (HP:0002909) | 3.15283958 |
44 | Metabolic acidosis (HP:0001942) | 3.08415708 |
45 | Abnormality of complement system (HP:0005339) | 3.08084045 |
46 | Lethargy (HP:0001254) | 3.02587138 |
47 | Hypercholesterolemia (HP:0003124) | 2.97195554 |
48 | Hemorrhage of the eye (HP:0011885) | 2.91918839 |
49 | Ragged-red muscle fibers (HP:0003200) | 2.90923184 |
50 | Abnormality of the Achilles tendon (HP:0005109) | 2.86876319 |
51 | Proximal tubulopathy (HP:0000114) | 2.85124512 |
52 | Purpura (HP:0000979) | 2.83332322 |
53 | Steatorrhea (HP:0002570) | 2.82415087 |
54 | Abnormality of glycolysis (HP:0004366) | 2.80526322 |
55 | Hepatocellular carcinoma (HP:0001402) | 2.74328040 |
56 | Vascular calcification (HP:0004934) | 2.73488692 |
57 | Cerebral edema (HP:0002181) | 2.71223750 |
58 | Achilles tendon contracture (HP:0001771) | 2.71181702 |
59 | Increased purine levels (HP:0004368) | 2.63415215 |
60 | Hyperuricemia (HP:0002149) | 2.63415215 |
61 | Reticulocytosis (HP:0001923) | 2.59442458 |
62 | Trismus (HP:0000211) | 2.58098904 |
63 | Vomiting (HP:0002013) | 2.53733088 |
64 | Alkalosis (HP:0001948) | 2.51630431 |
65 | Irritability (HP:0000737) | 2.51540282 |
66 | Spastic diplegia (HP:0001264) | 2.50554638 |
67 | Hypoglycemic seizures (HP:0002173) | 2.46703568 |
68 | Progressive muscle weakness (HP:0003323) | 2.45952802 |
69 | Abnormality of urine glucose concentration (HP:0011016) | 2.42995304 |
70 | Glycosuria (HP:0003076) | 2.42995304 |
71 | Increased serum ferritin (HP:0003281) | 2.41303923 |
72 | Cardiovascular calcification (HP:0011915) | 2.40173779 |
73 | Increased serum pyruvate (HP:0003542) | 2.39773353 |
74 | Malnutrition (HP:0004395) | 2.39514753 |
75 | Late onset (HP:0003584) | 2.39424819 |
76 | Hydroxyprolinuria (HP:0003080) | 2.39151206 |
77 | Abnormality of proline metabolism (HP:0010907) | 2.39151206 |
78 | Neonatal onset (HP:0003623) | 2.39119297 |
79 | Abnormality of carpal bone ossification (HP:0006257) | 2.37315740 |
80 | Microvesicular hepatic steatosis (HP:0001414) | 2.34521335 |
81 | Skin nodule (HP:0200036) | 2.34104740 |
82 | Myocardial infarction (HP:0001658) | 2.33852391 |
83 | Brushfield spots (HP:0001088) | 2.33325885 |
84 | Hyperacusis (HP:0010780) | 2.30565859 |
85 | Opisthotonus (HP:0002179) | 2.28727873 |
86 | Hypertensive crisis (HP:0100735) | 2.28260613 |
87 | Upper limb amyotrophy (HP:0009129) | 2.27350468 |
88 | Distal upper limb amyotrophy (HP:0007149) | 2.27350468 |
89 | Pancreatitis (HP:0001733) | 2.26953903 |
90 | Sensorimotor neuropathy (HP:0007141) | 2.26336399 |
91 | Dysostosis multiplex (HP:0000943) | 2.25638294 |
92 | Protrusio acetabuli (HP:0003179) | 2.23382412 |
93 | Enlarged kidneys (HP:0000105) | 2.23131885 |
94 | Systemic lupus erythematosus (HP:0002725) | 2.22875535 |
95 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.19801982 |
96 | Seborrheic dermatitis (HP:0001051) | 2.19743467 |
97 | Spontaneous abortion (HP:0005268) | 2.15260569 |
98 | Rough bone trabeculation (HP:0100670) | 2.14166914 |
99 | Rickets (HP:0002748) | 2.12680865 |
100 | Abnormality of reticulocytes (HP:0004312) | 2.11978361 |
101 | Petechiae (HP:0000967) | 2.11952507 |
102 | Loss of speech (HP:0002371) | 2.10706469 |
103 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.09202639 |
104 | Abnormal gallbladder morphology (HP:0012437) | 2.06923490 |
105 | Menorrhagia (HP:0000132) | 2.05670199 |
106 | Hypochromic microcytic anemia (HP:0004840) | 2.04552970 |
107 | Cholecystitis (HP:0001082) | 2.04198521 |
108 | Abnormal gallbladder physiology (HP:0012438) | 2.04198521 |
109 | Methylmalonic aciduria (HP:0012120) | 2.04138250 |
110 | Mitral stenosis (HP:0001718) | 2.03638359 |
111 | Abnormal cartilage morphology (HP:0002763) | 2.01647423 |
112 | Prolonged neonatal jaundice (HP:0006579) | 2.01048867 |
113 | Cholelithiasis (HP:0001081) | 2.00296581 |
114 | Acanthocytosis (HP:0001927) | 1.99123520 |
115 | Nausea (HP:0002018) | 1.98923678 |
116 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96325152 |
117 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96325152 |
118 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96325152 |
119 | Hypokinesia (HP:0002375) | 1.95510195 |
120 | Hepatic necrosis (HP:0002605) | 1.94998922 |
121 | Nuclear cataract (HP:0100018) | 1.94351729 |
122 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.92759751 |
123 | Abnormal ossification of hand bones (HP:0005921) | 1.89897260 |
124 | Flat acetabular roof (HP:0003180) | 1.89550145 |
125 | Nephrolithiasis (HP:0000787) | 1.88870918 |
126 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.88698608 |
127 | Mucopolysacchariduria (HP:0008155) | 1.88698608 |
128 | Elevated hepatic transaminases (HP:0002910) | 1.87509790 |
129 | Multiple enchondromatosis (HP:0005701) | 1.87455384 |
130 | Hepatosplenomegaly (HP:0001433) | 1.86983798 |
131 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.86207390 |
132 | Long palpebral fissure (HP:0000637) | 1.86110865 |
133 | Hand muscle atrophy (HP:0009130) | 1.85322164 |
134 | Insomnia (HP:0100785) | 1.85184900 |
135 | Glomerulonephritis (HP:0000099) | 1.84832083 |
136 | Abnormal trabecular bone morphology (HP:0100671) | 1.84138439 |
137 | Abnormal tarsal ossification (HP:0008369) | 1.83787989 |
138 | Abnormality of vitamin metabolism (HP:0100508) | 1.83430075 |
139 | Esophageal varix (HP:0002040) | 1.82901892 |
140 | Small epiphyses (HP:0010585) | 1.82108913 |
141 | Premature ovarian failure (HP:0008209) | 1.81799989 |
142 | Elevated alkaline phosphatase (HP:0003155) | 1.81126333 |
143 | Myopathic facies (HP:0002058) | 1.81057392 |
144 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.80891375 |
145 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.80891375 |
146 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.80891375 |
147 | Renal cortical cysts (HP:0000803) | 1.79072602 |
148 | Hyperphosphaturia (HP:0003109) | 1.77843048 |
149 | Polygenic inheritance (HP:0010982) | 1.77527720 |
150 | Abnormality of the gallbladder (HP:0005264) | 1.77379374 |
151 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76725188 |
152 | Orthostatic hypotension (HP:0001278) | 1.76495942 |
153 | Premature rupture of membranes (HP:0001788) | 1.76130802 |
154 | Fatigue (HP:0012378) | 1.74346710 |
155 | Testicular atrophy (HP:0000029) | 1.73408581 |
156 | Ulnar bowing (HP:0003031) | 1.72986601 |
157 | Nonimmune hydrops fetalis (HP:0001790) | 1.72940392 |
158 | Rhabdomyolysis (HP:0003201) | 1.72848552 |
159 | Back pain (HP:0003418) | 1.70833545 |
160 | Abnormality of macrophages (HP:0004311) | 1.70832114 |
161 | Axonal loss (HP:0003447) | 1.70828621 |
162 | Progressive external ophthalmoplegia (HP:0000590) | 1.70441405 |
163 | Hypertriglyceridemia (HP:0002155) | 1.69744441 |
164 | Truncus arteriosus (HP:0001660) | 1.69653321 |
165 | Distal lower limb amyotrophy (HP:0008944) | 1.69501661 |
166 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.68095561 |
167 | Vacuolated lymphocytes (HP:0001922) | 1.68072236 |
168 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.67343789 |
169 | Hyperthyroidism (HP:0000836) | 1.66036096 |
170 | Abnormality of iron homeostasis (HP:0011031) | 1.64512151 |
171 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.62063538 |
172 | Absent epiphyses (HP:0010577) | 1.62063538 |
173 | Abnormality of the thoracic spine (HP:0100711) | 1.62035479 |
174 | Deviation of the thumb (HP:0009603) | 1.61349199 |
175 | Abnormality of the tricuspid valve (HP:0001702) | 1.59478583 |
176 | Neonatal death (HP:0003811) | 1.57884936 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 8.29422971 |
2 | ERN1 | 4.28696702 |
3 | SIK1 | 3.77878684 |
4 | FGFR4 | 3.61625136 |
5 | SMG1 | 3.37623817 |
6 | WNK3 | 2.93902681 |
7 | TRIB3 | 2.53771818 |
8 | PRPF4B | 2.52198893 |
9 | WNK4 | 2.46687773 |
10 | FLT3 | 2.38033991 |
11 | INSRR | 2.33285723 |
12 | MST1R | 2.31378519 |
13 | TAOK3 | 2.22768627 |
14 | VRK2 | 2.09827791 |
15 | PKN2 | 2.09344574 |
16 | TAOK2 | 1.98452203 |
17 | CDK12 | 1.96066605 |
18 | OXSR1 | 1.94423128 |
19 | ERBB4 | 1.90400267 |
20 | TESK1 | 1.89085936 |
21 | ARAF | 1.64131736 |
22 | MAPK11 | 1.58764073 |
23 | PIM2 | 1.49375531 |
24 | PIK3CG | 1.47724046 |
25 | MET | 1.43342557 |
26 | PAK4 | 1.40992813 |
27 | PTK6 | 1.39060188 |
28 | MAP2K4 | 1.36591009 |
29 | ABL2 | 1.34608958 |
30 | KDR | 1.33923065 |
31 | EPHB1 | 1.28937339 |
32 | MAP2K3 | 1.23775631 |
33 | MAPK15 | 1.23564745 |
34 | TYK2 | 1.22260256 |
35 | SCYL2 | 1.19448373 |
36 | NEK1 | 1.18640345 |
37 | STK16 | 1.16535615 |
38 | PDK3 | 1.16144815 |
39 | PDK4 | 1.16144815 |
40 | GRK6 | 1.12809708 |
41 | PINK1 | 1.12611868 |
42 | MAP3K11 | 1.07590262 |
43 | NME1 | 1.06373022 |
44 | NEK9 | 1.04556107 |
45 | BUB1 | 1.03427460 |
46 | MAPKAPK3 | 1.03317271 |
47 | MAP3K10 | 1.02980536 |
48 | MAP3K8 | 1.02434907 |
49 | CDK7 | 1.01155870 |
50 | JAK2 | 0.96959368 |
51 | STK38L | 0.96101027 |
52 | LMTK2 | 0.94912689 |
53 | MAP3K3 | 0.91661021 |
54 | STK39 | 0.90529999 |
55 | PRKAA2 | 0.88279038 |
56 | MAP2K2 | 0.87743640 |
57 | TAOK1 | 0.86818960 |
58 | KSR2 | 0.86453157 |
59 | MAP3K7 | 0.83650100 |
60 | FRK | 0.83433443 |
61 | DAPK1 | 0.83329237 |
62 | CSF1R | 0.81933993 |
63 | TBK1 | 0.81363878 |
64 | DYRK1B | 0.80595376 |
65 | NME2 | 0.79846485 |
66 | MAPK4 | 0.79274119 |
67 | RPS6KB2 | 0.77514621 |
68 | SIK3 | 0.77422224 |
69 | MAP3K13 | 0.77402855 |
70 | BRAF | 0.74144112 |
71 | BMX | 0.73245271 |
72 | FGFR2 | 0.72928818 |
73 | BRSK1 | 0.72677146 |
74 | DAPK2 | 0.69468651 |
75 | CDK8 | 0.69077913 |
76 | GSK3A | 0.68542791 |
77 | TIE1 | 0.67930159 |
78 | TGFBR2 | 0.67546448 |
79 | PTK2 | 0.67117353 |
80 | TESK2 | 0.67072807 |
81 | ERBB2 | 0.67029385 |
82 | MAP2K6 | 0.65779994 |
83 | PRKCZ | 0.65208761 |
84 | LIMK1 | 0.62560195 |
85 | RIPK4 | 0.61985994 |
86 | AURKA | 0.61917438 |
87 | PDGFRA | 0.61197897 |
88 | IRAK4 | 0.60543387 |
89 | PRKACG | 0.58244047 |
90 | CAMK1D | 0.57791078 |
91 | PRKAA1 | 0.56602785 |
92 | SIK2 | 0.56366153 |
93 | PAK1 | 0.54598170 |
94 | SRPK1 | 0.54224534 |
95 | LRRK2 | 0.53685203 |
96 | CDK9 | 0.53489568 |
97 | CDC42BPA | 0.53164085 |
98 | PDPK1 | 0.52495356 |
99 | PRKD2 | 0.52317575 |
100 | IRAK2 | 0.51884146 |
101 | ILK | 0.51689756 |
102 | AKT2 | 0.51363400 |
103 | IRAK3 | 0.51161523 |
104 | MAP4K1 | 0.49982827 |
105 | CSNK1G1 | 0.48802064 |
106 | STK10 | 0.48287307 |
107 | JAK1 | 0.47274670 |
108 | RAF1 | 0.47046791 |
109 | CDK6 | 0.45975619 |
110 | TTK | 0.45766202 |
111 | MAP2K1 | 0.44510250 |
112 | ALK | 0.44474141 |
113 | MAPK12 | 0.44359225 |
114 | ICK | 0.44008665 |
115 | MAP3K9 | 0.43314505 |
116 | MAPKAPK2 | 0.43241115 |
117 | ZAP70 | 0.42954736 |
118 | CAMK2G | 0.41387331 |
119 | CDK4 | 0.41362165 |
120 | KIT | 0.41005146 |
121 | RIPK1 | 0.40693645 |
122 | SGK494 | 0.40433319 |
123 | SGK223 | 0.40433319 |
124 | MARK2 | 0.39923234 |
125 | TGFBR1 | 0.39852996 |
126 | CSK | 0.39162521 |
127 | FGFR3 | 0.38904630 |
128 | LATS2 | 0.38647983 |
129 | EIF2AK1 | 0.38404300 |
130 | PRKG2 | 0.37102510 |
131 | CHEK1 | 0.36953623 |
132 | MTOR | 0.36674379 |
133 | NTRK1 | 0.36178615 |
134 | PDK2 | 0.35329701 |
135 | PRKD3 | 0.35264439 |
136 | JAK3 | 0.34646329 |
137 | PRKCI | 0.34357114 |
138 | CDK11A | 0.33688149 |
139 | IGF1R | 0.33596266 |
140 | MOS | 0.33483049 |
141 | CSNK1G3 | 0.33274415 |
142 | LATS1 | 0.32801648 |
143 | EIF2AK3 | 0.31413717 |
144 | BTK | 0.31332493 |
145 | EEF2K | 0.31331250 |
146 | PRKCQ | 0.29454700 |
147 | PDK1 | 0.29222728 |
148 | RET | 0.26455319 |
149 | MAP3K6 | 0.24315323 |
150 | MAP3K1 | 0.23933355 |
151 | MAP3K2 | 0.23743847 |
152 | EPHB2 | 0.23528312 |
153 | EPHA2 | 0.20239829 |
154 | EGFR | 0.19801365 |
155 | ACVR1B | 0.19061767 |
156 | PBK | 0.19030774 |
157 | SGK3 | 0.18479719 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.93838236 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26209463 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.04042231 |
4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.89867014 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.87600734 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.82652187 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70627352 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68130489 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63449621 |
10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.61352666 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58182157 |
12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.47058860 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.41480657 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26809577 |
15 | Peroxisome_Homo sapiens_hsa04146 | 2.26555443 |
16 | DNA replication_Homo sapiens_hsa03030 | 2.16957892 |
17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.12390243 |
18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.04887645 |
19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.03909132 |
20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.95890487 |
21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92608135 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89735211 |
23 | Base excision repair_Homo sapiens_hsa03410 | 1.86664810 |
24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83969645 |
25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80189042 |
26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.73725966 |
27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.72185984 |
28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.70739834 |
29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.68526685 |
30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67777030 |
31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63922746 |
32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.63362658 |
33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57155858 |
34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55192940 |
35 | * Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53147198 |
36 | Proteasome_Homo sapiens_hsa03050 | 1.50782896 |
37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.47421305 |
38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46506797 |
39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46118276 |
40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.45243240 |
41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43729134 |
42 | Ribosome_Homo sapiens_hsa03010 | 1.43169639 |
43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42319345 |
44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.41852639 |
45 | Bile secretion_Homo sapiens_hsa04976 | 1.40371556 |
46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39043513 |
47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35110409 |
48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.31341386 |
49 | Spliceosome_Homo sapiens_hsa03040 | 1.29551158 |
50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26459080 |
51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23948303 |
52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23843012 |
53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23784451 |
54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.22353135 |
55 | Bladder cancer_Homo sapiens_hsa05219 | 1.18691156 |
56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17796833 |
57 | Sulfur relay system_Homo sapiens_hsa04122 | 1.17372376 |
58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13373610 |
59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12508413 |
60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12294055 |
61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.11882878 |
62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07287926 |
63 | ABC transporters_Homo sapiens_hsa02010 | 1.01452357 |
64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.99040038 |
65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95409010 |
66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92707532 |
67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90523014 |
68 | Mismatch repair_Homo sapiens_hsa03430 | 0.90302360 |
69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88119280 |
70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86555752 |
71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85921762 |
72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85862456 |
73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85507378 |
74 | Lysine degradation_Homo sapiens_hsa00310 | 0.83686919 |
75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76901764 |
76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75646439 |
77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74901623 |
78 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.69505628 |
79 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67858820 |
80 | RNA transport_Homo sapiens_hsa03013 | 0.67679785 |
81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65565886 |
82 | Shigellosis_Homo sapiens_hsa05131 | 0.63908014 |
83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61128865 |
84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61098914 |
85 | Apoptosis_Homo sapiens_hsa04210 | 0.60868279 |
86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58213752 |
87 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.57976277 |
88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55910013 |
89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55527003 |
90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52430197 |
91 | Cell cycle_Homo sapiens_hsa04110 | 0.51792780 |
92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51671022 |
93 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50325562 |
94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45949787 |
95 | Hepatitis C_Homo sapiens_hsa05160 | 0.45741352 |
96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45050034 |
97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44253766 |
98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.42889532 |
99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41354122 |
100 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.39549627 |
101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36749585 |
102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34704590 |
103 | Hepatitis B_Homo sapiens_hsa05161 | 0.33754268 |
104 | Influenza A_Homo sapiens_hsa05164 | 0.33656598 |
105 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33415869 |
106 | Salmonella infection_Homo sapiens_hsa05132 | 0.32579552 |
107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30047109 |
108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29705178 |
109 | Endocytosis_Homo sapiens_hsa04144 | 0.29242292 |
110 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.28887617 |
111 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.28125464 |
112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27460214 |
113 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.26090477 |
114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25167003 |
115 | Pertussis_Homo sapiens_hsa05133 | 0.24898443 |
116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20785722 |
117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20445983 |
118 | Insulin resistance_Homo sapiens_hsa04931 | 0.18902570 |
119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.18030046 |
120 | Prion diseases_Homo sapiens_hsa05020 | 0.14677997 |
121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14456072 |
122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07837766 |
123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05978770 |
124 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04047962 |
125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03657940 |
126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1652905 |
127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1595898 |
128 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1581165 |
129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1360661 |
130 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.1343123 |
131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1302969 |
132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1285334 |
133 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1011244 |
134 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0815471 |
135 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0731781 |
136 | Lysosome_Homo sapiens_hsa04142 | -0.0713702 |
137 | Protein export_Homo sapiens_hsa03060 | -0.0681107 |
138 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0363051 |
139 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0351994 |
140 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0219473 |
141 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0146835 |
142 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0113543 |
143 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0002228 |